Long-term results and risk factors of quadruple immunosuppression in renal transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):1111-2. doi: 10.1016/s0041-1345(98)01924-1.
No abstract available

MeSH terms

  • Analysis of Variance
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Survival / drug effects
  • Graft Survival / physiology*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Postoperative Complications / classification
  • Postoperative Complications / epidemiology
  • Prednisone / therapeutic use
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Prednisone